New CAR-T Cell Therapy Shows Promise ... variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

Childhood leukemia symptoms can be subtle. Learn how to recognize early warning signs and when to seek medical advice.

In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...

B-cell acute lymphoblastic leukemia (B-ALL ... antigen receptor (CAR) T cell therapy, obecabtagene autoleucel (obe-cel), experienced ... Researchers from Children's Hospital of Philadelphia ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

CAR-T pipeline advances, with blood cancers at the forefront of development, driving new treatment innovations.

By reviewing this smear, lab technicians can determine if each kind of blood cell is normal in appearance ... to develop a treatment plan. Leukemia doesn’t typically form tumors, so imaging ...

“But back in the day, it was all science fiction.” Although various CAR T-cell therapies are approved in lymphoma, leukemia, and multiple myeloma, patient access has been slow to expand both ...

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...